| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.3M | -26.8% |
| Cost of Revenue | $42.0M | -36.4% |
| Gross Profit | $7.3M | +506.0% |
| R&D Expense | $1.8M | -21.7% |
| Operating Income | -$11.7M | +28.3% |
| Pre-tax Income | -$11.4M | +29.1% |
| Income Tax | -$94K | -883.3% |
| Net Income | -$11.3M | +29.8% |
| EPS (Basic) | -$0.77 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $8.0M | -49.7% |
| Inventory | $12.3M | +2.9% |
| Current Assets | $27.1M | -33.4% |
| Total Assets | $61.5M | -20.8% |
| Current Liabilities | $13.3M | -21.1% |
| Total Liabilities | $20.2M | -28.2% |
| Stockholders' Equity | $41.3M | -16.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +83.5% |
| Capital Expenditures | $828K | -11.6% |
| Investing Cash Flow | -$4.1M | +29.0% |
| Financing Cash Flow | $1.2M | -95.7% |
| Free Cash Flow | -$3.0M | +78.8% |
| +40.8% |
| EPS (Diluted) | -$0.77 | +40.8% |